100 Percent Efficacy, Here Are 7 Facts About The Russian Cancer Vaccine That Is In The Global Spotlight

JAKARTA - The medical world has just been shocked by news from Russia. A cancer vaccine called Enteromix is claimed to have successfully demonstrated 100 percent efficacy in early human trials.

This result immediately attracted global attention because patients who participated in the tumor shrinkage without serious side effects.

Here are 7 interesting facts about the Russian cancer vaccine Entertainment that has shocked the medical world, as reported by the NDTV page.

1. Created with mRNA Technology

Enteromix uses mRNA technology, the same as those used for the COVID-19 vaccine. The difference is, this time the technology is directed to train the immune system in order to recognize and destroy cancer cells.

2. Preliminary Results: 100 percent Efficacy

In an initial trial involving 48 collorectal cancer patients, this vaccine proved safe and effective. The patient's tumor is shrinking, and no harmful side effects have been reported.

3. Therapy Adjusted to Tumor Genetics

The greatest advantage of Enteromix is in its personalized nature. Each dose of vaccine is adjusted to the genetic profile of the patient's tumor, so it is more targeted than the method of 'one drug for all'.

4. Officially Announced at the World Economic Forum

The discovery was announced at the St. Petersburg International Economic Forum 2025. Russia is now awaiting approval from the Ministry of Health to move to the next stage.

5. Different from other Cancer Vaccines

For decades, many cancer vaccines have failed to show tangible results. Enteromix brings two new things:

- The patient's genetic-based personal design.

- The flexibility of mRNA, which allows vaccines to be quickly developed for other types of cancer.

6. New Hope for Patients around the world

If successful in passing the next major trial, Enteromix could bring a new era of cancer treatment, the reason:

- Safer, due to lack of side effects.

- More effective, because it is in accordance with the conditions of each patient.

- More humane, compared to chemotherapy that often weakens the body.

7. Challenges Still exist

Although the initial results were surprising, experts warn to remain careful. Some of the challenges that must be overcome:

- The production process of a complicated personal vaccine.

- The need for cold chains for mRNA distribution.

- Costs and infrastructure that may be high, especially in developing countries.